Literature DB >> 2898226

Neuroactive substances in cerebrospinal fluid. Normal and pathological regulatory mechanisms.

R M Post1, D R Rubinow, M A Kling, W Berrettini, P W Gold.   

Abstract

Mesh:

Substances:

Year:  1988        PMID: 2898226     DOI: 10.1111/j.1749-6632.1988.tb31808.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  Reduced somatostatin in subgenual anterior cingulate cortex in major depression.

Authors:  Adam Tripp; Rama S Kota; David A Lewis; Etienne Sibille
Journal:  Neurobiol Dis       Date:  2011-01-11       Impact factor: 5.996

2.  Human cerebrospinal fluid increases the excitability of pyramidal neurons in the in vitro brain slice.

Authors:  Andreas Bjorefeldt; Ulf Andreasson; Jonny Daborg; Ilse Riebe; Pontus Wasling; Henrik Zetterberg; Eric Hanse
Journal:  J Physiol       Date:  2014-11-25       Impact factor: 5.182

3.  Neuromodulation of fast-spiking and non-fast-spiking hippocampal CA1 interneurons by human cerebrospinal fluid.

Authors:  Andreas Bjorefeldt; Pontus Wasling; Henrik Zetterberg; Eric Hanse
Journal:  J Physiol       Date:  2016-01-18       Impact factor: 5.182

Review 4.  Reduced brain somatostatin in mood disorders: a common pathophysiological substrate and drug target?

Authors:  Li-Chun Lin; Etienne Sibille
Journal:  Front Pharmacol       Date:  2013-09-09       Impact factor: 5.810

5.  Characterization of GABAergic marker expression in the chronic unpredictable stress model of depression.

Authors:  Mounira Banasr; Ashley Lepack; Corey Fee; Vanja Duric; Jaime Maldonado-Aviles; Ralph DiLeone; Etienne Sibille; Ronald S Duman; Gerard Sanacora
Journal:  Chronic Stress (Thousand Oaks)       Date:  2017-08-03

6.  Human Cerebrospinal fluid promotes long-term neuronal viability and network function in human neocortical organotypic brain slice cultures.

Authors:  Niklas Schwarz; Ulrike B S Hedrich; Hannah Schwarz; Harshad P A; Nele Dammeier; Eva Auffenberg; Francesco Bedogni; Jürgen B Honegger; Holger Lerche; Thomas V Wuttke; Henner Koch
Journal:  Sci Rep       Date:  2017-09-25       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.